All Type of News
MFDS about to join in EU White List after PIC/S & ICH
It was observed the Ministry of Food and Drug Safety(MFDS) is about to join in the EU ‘White List’ after PIC/S and ICH.
The MFDS announced the ministry has continuously worked on joining in international organization...
‘Draft of the Expenditure Report for Economic Benefits’ completed
A draft of the ‘Expenditure Report for Economic Benefits,’ which will play a key role in exposing rebates, was completed and delivered to related associations and organization.
The Ministry of Health and Welfare(MOHW...
JW Life Science acquires commercialization approval of epilepsy therapy ‘Levetiram’
A new-concept solution, which relieve seizure for epilepsy patients, will be released in Korea.
JW Life Science(CEO Sung-Nam Cha) announced on the 12th that it has acquired commercialization approval of ‘Levetiram In...
Pfizer Pharmaceuticals Korea’s ‘Caduet Tab 10/20mg’ suspended sales for 45 days
A Pfizer Pharmaceuticals Korea’s combination drug for hypertension and hyperlipidemia, ‘Caduet Tab 10/20mg,’ has taken 45 days of administrative measure to suspend its sales activities.
On the 12th, the Ministry of F...
Opinion differences between prosecution and Novartis at rebate trialAcceptance or denial of the Novartis’ case in which the company was charged for a new concept of illegal rebate provision through the mass media and PR agencies has not been dec...
|
What will be changed after resignation of Chairman Kyeong-Ho Lee
Leaving a year left for his term of office, Chairman Kyeong-Ho Lee of the Korea Pharmaceutical Manufacturers Association(KPMA) announced resignation on the 12th, which attracted attention of the industry over the asso...
Kyeong-Ho Lee announces resignation from KPMA Chairman
Chairman Kyeong-Ho Lee of the Korea Pharmaceutical Manufacturers Association(KPMA) will resign from this position a regular general meeting on the coming February.
Chairman Kyeong-Ho Lee announced the resignation at ...
LegoChem Bio signs ADC research license agreement with Takeda
LegoChem Biosciences(hereinafter referring to LegoChem Bio) announced it signed a ADC(antibody-drug ) research license agreement with Takeda on the 11th of January. This is the first license agreement with a global ph...
Hanmi Pharm introduces platform technology & new drug pipeline at JP Morgan ConferenceOn the 12th, Hanmi Pharm(CEO Kwan-Soon Lee) announced it was revealed the 2017 R&D strategy at the ‘35th JP Morgan Healthcare Conference’ held at Westin St. Francis in San Franc...
|
Implementation of Pharmaceutical Product Approval Renewal for every 5 years
The Pharmaceutical Product Approval Renewal System will be implemented from the year of 2018 for every 5 years.
At the 2017 work report, the Ministry of Food and Drug Safety(MFDS) announced to implement the Pharmace...
